PubRank

Study of Impact of Routine "Clinical Cancer Department/Supportive Care Department" Consultation on the Prescription of an Additional Line of Chemotherapy

Clinical Trial ID NCT00905281

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00905281

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001 44.67
2 The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993 38.99
3 A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 1995 25.96
4 Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998 12.60
5 Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 1990 8.90
6 A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996 7.96
7 A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 2003 4.77
8 Is breast cancer survival improving? Cancer 2004 2.73
9 Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer. J Clin Oncol 2001 1.84
10 Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group. Eur J Cancer 2005 1.80
11 A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics 1980 1.74
12 The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis. Psychooncology 2007 1.46
13 Palliative care consultations: how do they impact the care of hospitalized patients? J Pain Symptom Manage 2000 1.38
14 Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer 2005 1.37
15 The benefits of a hospital-based inpatient palliative care consultation service: preliminary outcome data. J Palliat Med 2005 1.17
16 Impact of chemotherapy beyond the first line in patients with metastatic breast cancer. Breast Cancer Res Treat 2007 1.16
17 The impact of a palliative medicine consultation service in medical oncology. Support Care Cancer 2002 0.89
18 Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer. Breast Cancer Res Treat 2005 0.89
19 Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer. Breast Cancer Res Treat 2006 0.86
20 The validity of the French version of the GHQ-28 and PSYDIS in a community sample of 20 year olds in Switzerland. Eur Arch Psychiatry Neurol Sci 1989 0.84
21 Role of health-related quality of life in palliative chemotherapy treatment decisions. J Clin Oncol 2002 0.83
22 Factors determining outcome after third line chemotherapy for metastatic breast cancer. Breast 2007 0.78
23 [Prospective study on the quality of care and quality of life in advanced cancer patients treated at home or in hospital: intermediate analysis of the Trapado study]. Bull Cancer 2006 0.78
24 Dimensions of cancer locus of control scale as predictors of psychological adjustment and survival in breast cancer patients. Psychol Rep 2005 0.78
25 Profile and evaluation of a palliative medicine consultation service within a tertiary teaching hospital in Sydney, Australia. J Pain Symptom Manage 2002 0.77
26 [Validation of the French version of the Princess Margaret Hospital Patient Satisfaction with their Doctor Questionnaire]. Rev Mal Respir 2006 0.75
Next 100